Microbiological Estimation of Nasal Spray Containing Naltrexone Hydrochloride
https://doi.org/10.33380/2305-2066-2020-9-4-116-120
Abstract
Introduction. In order to standardize the quality indicators during the expected shelf life of the developed drug naltrexone hydrochloride in the form of a nasal spray containing a high concentration of poloxamer and benzalkonium chloride as a preservative, a microbiological study was carried out. The possibility of using the membrane filtration method for testing prototypes recommended by the State Pharmacopoeia XIV.
Aim. Study and selection of test conditions for the «microbiological purity» indicator of nasal spray samples containing naltrexone hydrochloride.
Materials and methods. As an object of research, a naltrexone hydrochloride nasal spray was used. When analyzing the microbiological purity, the membrane filtration method recommended in the State Pharmacopoeia XIV.
Results and discussion. As part of the study, it was found that the samples of the drug meet the requirements for a microbiological indicator for drugs of category 2. Testing the suitability of the method for samples of the dosage form showed that the antimicrobial effect of the drug was completely removed by washing the filter, which was proved by inoculation of indicator test microorganisms, the quantitative and qualitative nature of growth, which did not differ from the control without the drug.
Conclusion. As a result of the studies carried out, the optimal test conditions for the «Microbiological purity» indicator for the nasal spray containing naltrexone hydrochloride were selected and substantiated.
About the Authors
Yu. M. DomninaRussian Federation
Yuliya M. Domnina
86, Vernadsky av., Moscow, 119571,
21/1, Skolkovskoye highway, Moscow, 121353
V. V. Suslov
Russian Federation
Vasiliy V. Suslov
86, Vernadsky av., Moscow, 119571,
21/1, Skolkovskoye highway, Moscow, 121353
N. E. Grammatikova
Russian Federation
Nataliya E. Grammatikova
86, Vernadsky av., Moscow, 119571,
11/1, Bolshaya Pirogovskaya str., Moscow, 119435
S. A. Kedik
Russian Federation
Stanislav A. Kedik
86, Vernadsky av., Moscow, 119571,
21/1, Skolkovskoye highway, Moscow, 121353
References
1. Domnina Y.M., Kedik S.A., Suslov V.V., Shnyak E.A. Rationale for the selection of auxiliary components for the naltrexone hydrochloride nasal spray. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development & registration. 2018;4:73–77. (In Russ.).
2. Domnina Y. M., Kedik S. A., Suslov V. V., Shnyak E.A. Development of Naltrexone Hydrochloride Nasal Spray. Nauchnyy forum: Meditsina, biologiya i khimiya. 2018. P. 69–73. (In Russ.).
3. Domnina Y. M., Kedik S. A., Suslov V. V., Shnyak E. A. Rationale for the choice of naltrexone hydrochloride nasal spray thickener. Sbornik tezisov. (In Russ.).
4. GF XIV OFS 1.2.4.0002.18 «Mikrobiologicheskaya chistota» (In Russ.).
5. Sandle T., Skinner K., Yeandle E. Optimal conditions for the recovery of bioburden from pharmaceutical processes: a case study. European Journal of Parenteral & Pharmaceutical Sciences. 2013;18(3):84–90.
6. Yaremchuk A. A., Khishova O. M., Polovko N. P. Microbiological rationale for the use of benzalkonium chloride in a soft dosage form for external use. Vestnik farmatsii. 2012;2:39–45. (In Russ.).
7. Jira T., Panzig B., Pohloudek-Fabini R. Antimicrobial activity of benzalkonium chloride in potential contact lens fluids. Pharmazie. 1982;37(8):587–90.
Review
For citations:
Domnina Yu.M., Suslov V.V., Grammatikova N.E., Kedik S.A. Microbiological Estimation of Nasal Spray Containing Naltrexone Hydrochloride. Drug development & registration. 2020;9(4):116-120. (In Russ.) https://doi.org/10.33380/2305-2066-2020-9-4-116-120